Scott Whitney

NanO2® is a combustion catalyst diesel fuel additive that reduces emissions, improves fuel efficiency and increases engine performance, all while reducing combustion temperatures. Testing in real-world environments has resulted in up to 8% fuel consumption reduction and 20-50% reductions of emissions without the requirements of costly engine modifications. Features Reduces Green House Gas Emissions Cleans Fuel Injectors and Removes Carbon Deposits Improves Engine Life Increased Lubrication to Injectors and Combustion Chamber

QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation.

Ductor Corporation is a Finnish biotechnology company providing biogas operators with a unique portfolio of proprietary, patented and tested technologies for improving the profitability and stability of their biogas businesses. Ductors biological fermentation technology removes a controlled amount of nitrogen from the substrate prior to the anaerobic digestion process. Ductor promotes biogas as one of the most important renewable energy sources, while supplying important food production components as fertilizers.

NanO2® is a combustion catalyst diesel fuel additive that reduces emissions, improves fuel efficiency and increases engine performance, all while reducing combustion temperatures. Testing in real-world environments has resulted in up to 8% fuel consumption reduction and 20-50% reductions of emissions without the requirements of costly engine modifications. Features Reduces Green House Gas Emissions Cleans Fuel Injectors and Removes Carbon Deposits Improves Engine Life Increased Lubrication to Injectors and Combustion Chamber

QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation.

At Liberty Tire Recycling, sustainability is at the heart of everything we do. As North Americas leading tire recycler, we reclaim and repurpose over 4.7 billion pounds of rubber annually, keeping scrap tires out of landfills and transforming them into valuable, sustainable products. With 50+ collection, processing, and manufacturing facilities and over 4,000 employees across the U.S. and Canada, we provide innovative recycling solutions that support a circular economy, reduce environmental impact, and promote a cleaner, greener future. Our core values guide our mission: ✔ Safety – Sending everyone home safely, every day. ✔ People – Empowering individuals and fostering growth. ✔ Integrity – Doing the right thing, always. ✔ Innovation – Embracing change and leading the industry. ✔ Teamwork – Collaborating to drive success. ✔ Sustainability – Creating long-term value for our planet. Beyond recycling, we actively support communities through tire cleanup initiatives, remediating 150+ dump sites since 2011. Our goal? 100% beneficial tire reuse by 2032. Join us in Driving a Greener Tomorrow.